Delhi Man Takes HIV Prevention Drugs on AI Advice, Lands in ICU
hiv
New Delhi: A Delhi-based man is reportedly in a critical condition after consuming HIV preventive medication based on guidance received from an artificial intelligence (AI) platform, renewing concerns over self-medication and the growing reliance on digital tools for medical advice.
As per available information, the individual allegedly began taking HIV post-exposure prophylaxis (PEP) drugs without consulting a qualified healthcare professional. Shortly after initiating the medication, he developed serious health complications and had to be admitted to a hospital, where doctors described his condition as critical. The adverse reaction is suspected to be linked to the unsupervised use of the drugs.
Medical professionals have reiterated that HIV preventive medicines are prescription-only drugs and should be taken strictly under medical supervision. These medicines are recommended only after proper medical evaluation, and inappropriate or unnecessary intake can result in severe side effects, including potentially life-threatening drug reactions.
The incident has highlighted the risks associated with relying on AI-based platforms for health-related decisions. Experts have cautioned that while such tools may provide general information, they cannot evaluate an individual’s medical history, current health status, or suitability for specific medications, making them unsafe substitutes for professional medical advice.
According to a report by The Times of India, doctors and public health experts have urged people to avoid self-medication and to consult registered medical practitioners before starting any treatment, especially for serious conditions such as HIV prevention. They also stressed the need for greater public awareness about the limitations of AI-generated health advice.
